Also in AAV land, 1st pres on an IgM cleaving enzyme to enable AAV re-dosing [210]. Work on IgG degraders previously received a lot attention; Asokan lab show the disc. of an IgM degrader & feasibility of combining the two for more robust amelioration of anti-AAV immunity (17/26)
Preparing slides for #genetherapy at Swiss Society of Medical Genetics. I use Adobe Animate/Flash🤯. Could be worse (Powerpoint). Asked #chatgpt to write code to squiggle ellipses. Took way too long but it worked @SonjaSucic @DrJo_Ng@HesterChu@danielintheory@JIMD_Editors
Great opportunity to do a PhD on "Gene therapy for Alkaptonuria" with @LivuniLCaMS @UCL_IfWH Supervisors: George Bou-Gharios, Jim Gallagher, @SimonWad@Dr_RKarda@_BSGCT@ESGCT@UCLTRO @AKUSociety
https://t.co/rFSvbCG01D